IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 50 filers reported holding IMMUNOCORE HLDGS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,105,979 | -8.3% | 3,913,410 | +5.9% | 0.04% | -2.4% |
| Q2 2023 | $221,581,580 | +32.8% | 3,695,490 | +9.5% | 0.04% | +27.3% |
| Q1 2023 | $166,875,278 | +35.8% | 3,375,309 | +56.8% | 0.03% | +32.0% |
| Q4 2022 | $122,869,769 | +287.9% | 2,152,966 | +219.1% | 0.02% | +257.1% |
| Q3 2022 | $31,672,000 | -32.9% | 674,733 | -46.7% | 0.01% | -30.0% |
| Q2 2022 | $47,230,000 | +17.7% | 1,265,912 | -5.7% | 0.01% | +42.9% |
| Q1 2022 | $40,136,000 | -17.1% | 1,342,359 | -5.1% | 0.01% | -12.5% |
| Q4 2021 | $48,420,000 | +24.2% | 1,414,150 | +34.4% | 0.01% | +14.3% |
| Q3 2021 | $39,000,000 | +242.6% | 1,052,075 | +260.9% | 0.01% | +250.0% |
| Q2 2021 | $11,383,000 | +8.1% | 291,512 | +17.9% | 0.00% | 0.0% |
| Q1 2021 | $10,530,000 | – | 247,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |